Medline Inc. (MDLN)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $bn | - | - | 21 | 23 | 26 | 28 | 30 | 31 |
| Operating profit | $bn | 2 | 2 | ||||||
| Net profit | $bn | - | - | -0 | 0 | 1 | 1 | 1 | 1 |
| EPS reported | $ | 1.43 | 0.86 | ||||||
| Operating cashflow per share | $ | 2.15 | 2.32 | ||||||
| Capex per share | $ | 0.55 | 0.04 | ||||||
| FCF per share | $ | 1.60 | 2.36 | ||||||
| Free cash flow | $bn | 1 | 2 | ||||||
| Net debt | $bn | 11 | 10 | ||||||
| Book value equity | $bn | 11 | 12 | ||||||
| Book value per share | $ | 13.22 | 13.44 | ||||||
| Number of shares | m | 812 | 861 | ||||||
| DPS (TTM paid) | $ | 0.64 | 0.11 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | 42.55 | ||||||
| P/B LTM | x | 3.18 | 2.95 | ||||||
| P/S LTM | x | 1.20 | 1.14 | ||||||
| P/FCF LTM | x | 26.29 | 16.83 | ||||||
| EV/EBITDA LTM | x | 22.91 | 17.55 | ||||||
| EV/Sales LTM | x | 1.57 | 1.35 | ||||||
| Earnings Yield LTM | % | +3.40% | +2.35% | ||||||
| FCF Yield | % | +3.80% | +5.94% | ||||||
| Quality | |||||||||
| ROE | % | +10.79% | +5.45% | ||||||
| ROIC | % | +5.69% | +4.04% | ||||||
| Operating margin | % | +7.78% | +6.07% | ||||||
| Gross margin | % | +26.44% | +25.02% | ||||||
| FCF/Sales | % | +4.56% | +6.77% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -5.92% | -43.42% | ||||||
| Sales Growth YoY | % | +11.47% | +17.38% | ||||||
| Net Income Growth YoY | % | -3.42% | -42.42% | ||||||
| FCF Growth | % | -7.69% | +44.20% | ||||||
| Operating Profit Growth | % | -0.58% | -18.38% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +1.52% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | +44.61% | +13.59% | ||||||
| FCF/Debt | x | 0.10 | 0.16 | ||||||
| Net Debt/EBITDA | x | 5.44 | 4.05 | ||||||
| EBIT/Net interest | x | 2.72 | 2.50 | ||||||
| Net debt/market cap | % | +36.83% | +41.62% | ||||||
| Net debt/Equity | x | 0.99 | 0.86 | ||||||
| Gross debt/equity | x | 1.17 | 1.09 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free